title: Treating cervical cancer: Breast and Cervical Cancer Prevention and Treatment Act patients.
abstract: OBJECTIVE
  To investigate cervical cancer treatment of patients enrolled under the Breast and Cervical Cancer Prevention and Treatment Act in Georgia.
  
  
  METHODS
  Georgia Comprehensive Cancer Registry and Medicaid enrollment/claims were used to identify enrollees with preinvasive disease (n = 1149) and invasive cervical cancer (n = 444). Logistic regressions were used to estimate factors associated with the odds of receiving: (1) cancer workup, (2) precancerous procedure, (3) surgery, (4) radiation, and (5) chemotherapy.
  
  
  RESULTS
  Preinvasive disease cases with cervical intraepithelial neoplasia 3, in situ, a comorbidity or without a Commission on Cancer approved hospital nearby were more likely to receive surgery. Among invasive cases, later stage was associated with higher odds of receiving radiation or chemotherapy. Black patients were less likely to have surgery than white patients regardless of preinvasive (P < .01) or invasive status (P = .05).
  
  
  CONCLUSIONS
  Treatment patterns among Georgia Medicaid cases appear appropriate to stage but 18% with invasive cervical cancer received no cancer treatment, although Medicaid enrolled.
authors: Department of Health Policy and Management, Rollins School of Public Health, Emory University, Atlanta, GA, USA.
authors: Li-Nien
authors: LN
authors: Chien
authors: E Kathleen
authors: EK
authors: Adams
authors: Lisa C
authors: LC
authors: Flowers
mesh_terms: D000328:Adult; D005260:Female; D005845:Georgia; D006801:Humans; D008484:Medicaid; D008875:Middle Aged; D011247:Pregnancy; D014481:United States; D002583:Uterine Cervical Neoplasms / Q000628:therapy*; D055815:Young Adult